Other competitors in the healthcare sector include: NewLink Genetics Corp (NLNK), Peregrine Pharmaceuticals (PPHM), and BioSante Pharmaceuticals, Inc. (BPAX).
In fairness, there might be a few signs of life: Clovis and NewLink got out in the 4th quarter and several others are rumored to be expecting to get out early in 2012.